Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Biomarin Pharmaceutical Inc

NASDAQ: BMRN · Life Sciences · 7 alerts · CIK 1048477

Share price
$57.99Close, Nov 16
Market cap
$11.2B
Shares outstanding
193.69MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Biomarin Pharmaceutical Inc filings on SEC EDGAR ↗

9:27 AM ET 8-K
Executive Compensation

Biomarin Pharmaceutical Executive Compensation

BioMarin Pharmaceutical Inc. increased its board size from ten to eleven members and appointed Robert Plenge, M.D., Ph.D., as an independent director. Dr. Plenge will receive standard non-employee director fees and was granted restricted stock units (RSUs) valued at $400,000, which vest just prior to the company's next annual meeting.

Counterparty
Robert Plenge

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.